Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malaria | D008288 | EFO_0001068 | B54 | — | 2 | — | — | — | 2 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | — | 1 | — | — | — | 1 |
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | — | 1 |
Communicable diseases | D003141 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Pyronaridine |
INN | pyronaridine |
Description | Pyronaridine is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1 |
PDB | — |
CAS-ID | 74847-35-1 |
RxCUI | — |
ChEMBL ID | CHEMBL35228 |
ChEBI ID | — |
PubChem CID | 5485198 |
DrugBank | — |
UNII ID | TD3P7Q3SG6 (ChemIDplus, GSRS) |